The OIS Situation Room: Navigating Healthcare in a Shifting World Order

PODCAST EPISODE 421

Click here to watch the video version of this podcast.

At this year’s Retina Innovation Summit, industry experts and leaders gathered in a two-part discussion on investment trends, regulatory environment and FDA changes, emerging therapies in ophthalmology, and more. Panelists include: Laura Feinleib, Managing Director at Redmile Group; Derrick Li, Chief Strategy Officer at ODC Life Sciences; Cameron Taylor, Managing Director at BofA Securities | Life Sciences; Wayne Caulder, Vice President & General Manager of Surgical (U.S. & Canada) at Bausch + Lomb; Paul Hallen, Vice President & Distinguished Fellow at Alcon; Nida Sen, MD, VP, Ophthalmology Strategy & Development Head at Sanofi; and Julian Smith, General Manager Portfolio Commercial Strategy – Eye Care at AbbVie.

In this panel learn about:
🔹Investment trends in public and private markets
🔹Regenerative therapies, such as gene therapy and cell therapy
🔹The impact of patient and therapy adoption challenges—and how to navigate them
🔹Advice for entrepreneurs and start-ups on the best key strategies on driving partnership interest and networking